首页> 外文OA文献 >The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily

【2h】

The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily

机译：III期，双盲，并行组对照对氨氯地平10毫克的对照研究，每日一次每天一次每天都不充分地反应氨氯地平5毫克

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
T Fujiwara; Y Ii; J Hatsuzawa; H Murase; T Watanabe; M Murakami; N Kimura; J Buch; T Tsuchihashi; T Saruta;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily. [J] . Fujiwara T, Ii Y, Hatsuzawa J Journal of human hypertension . 2009,第8期

机译：在日本原发性高血压患者中，每天对氨氯地平10 mg的反应不充分，对氨氯地平5 mg每天一次的反应不足的III期，双盲，平行组对照研究。
2. Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study [J] . Kazuaki Shimamoto, Naoyuki Hasebe, Sadayoshi Ito, Hypertension research: Official journal of the Japanese Society of Hypertension . 2014,第1期

机译：硝苯地平控释40 mg b.i.d.日本原发性高血压患者对硝苯地平控释40 mg q.d.反应不充分：III期，随机，双盲和平行组研究
3. Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study [J] . RakugiH., OgiharaT., MiyataY., Clinical therapeutics . 2012,第4期

机译：日本轻度至中度原发性高血压患者与Candesartan Cilexetil和苯磺酸氨氯地平联合疗法与Candesartan Cilexetil单一疗法和Amlodipine苯磺酸盐联合疗法的疗效和耐受性评估：多中心，12周，随机，双盲，安慰剂控制的平行小组研究
4. Letting Patients' Daily Living Information Speak: A Novel Approach to Study Geriatric Patients with Dementia and Hypertension [C] . Weifeng Xu, William R. Betz, Stephen T. Frezza, World Congress on Engineering and Computer Science . 2010

机译：让患者的日常生活信息发言：一种研究痴呆患者和高血压患者的新方法
5. A Phase 1B, Double-blind, Placebo-controlled, Parallel-group, Multi-dose Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis and Fecal Fat in Subjects with Functional Constipation [D] . Oduyebo, Ibironke. 2018

机译：1B，双盲，安慰剂控制，并行组，NGM282对结肠转运，胆汁酸痛和患者功能性便秘的粪便脂肪的药物动力学的多剂量研究
6. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week multicenter randomized double-blind Phase III clinical study [O] . Sang-Hyun Ihm, Hui-Kyung Jeon, Tae-Joon Cha, 2016

机译：S-氨氯地平和替米沙坦的两种固定剂量组合（CKD-828）与S-氨氯地平单药治疗在S-氨氯地平单药治疗不能充分控制的高血压患者中的疗效和安全性：8周多中心随机双盲 III期临床研究
7. Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study [O] . Kazuaki Shimamoto, Naoyuki Hasebe, Sadayoshi Ito, 2013

机译：NifeDipine控释40 mg B.I.D.D.在日本患者的基础高血压患者中，均对硝苯地平控释40毫克Q.D的反应不充分。：III期，随机，双盲和平行群体研究

The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily

著录项

引文网络

相似文献

相关主题

期刊订阅